Pharmacy World and Science

, Volume 27, Issue 3, pp 197–201 | Cite as

Methylphenidate: Use in Daily Practice

  • Jacqueline G. HugtenburgEmail author
  • Judith E. Griekspoor
  • Ingrid De Boer
  • Eibert R. Heerdink
  • Yung Hwo Tso
  • Antoine C. G. Egberts


Objective: With the aim of getting more insight into compliance of children using methylphenidate, we studied the day-to-day use of the drug. In addition, the efficacy and side effects of treatment, stopping, switching to other drugs and the use of additional psychoactive drugs in daily practice were studied.

Method: On the basis of pharmacy records, the use of methylphenidate by 52 children was studied. Two parameters for compliance were calculated. By means of a questionnaire, parents were asked about their children’s compliance with the use of methylphenidate as well as about their experience with treatment.

Main outcome measure: Compliance, use of methylphenidate in weekends and holidays, self-reported efficacy, side effects, stopping and switching to other drugs.

Results: Depending on the parameter calculated, the percentage of children with a good compliance varied from 25 to 47%. About 65% of the children used less or no methylphenidate in the weekends and holidays. Sixty-five percent of the parents reported to pass over a dose once in a while. According to 61% of the parents (n = 28) the efficacy of methylphenidate was good or very good. Nine (33%) of 28 children stopped using methylphenidate. Seven children stopped using the drug because of side-effects or lack of efficacy. Seven children switched to other psychoactive drugs. Fifty-seven percent of all children used additional psychoactive drugs.

Conclusion: The percentage of children having a good compliance calculated on the basis of pharmacy records is rather low. This is partly the result of the decreased use of methylphenidate in the weekends and holidays.


Children Compliance Drug holiday Efficacy Methylphenidate Pharmacy records Side effects The Netherlands 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Safer, DJ, Krager, JM. 1994The increased rate of stimulant treatment for hyperactive/inattentive students in secondary schoolsPediatrics944624PubMedGoogle Scholar
  2. Zwi, M, Ramchandani, P, Joughin, C. 2000Evidence and belief in ADHDBMJ3219756CrossRefPubMedGoogle Scholar
  3. Schirm, E, Tobi, H, Zito, JM. 2001Psychotropic medication in children: a study from the NetherlandsPediatrics108e25CrossRefPubMedGoogle Scholar
  4. Berbatis, CG, Sunderland, VB, Bulsara, M. 2002Licit psychostimulant consumption in Australia, 1984–2000: international and jurisdictional comparisonMed J Aust17753943PubMedGoogle Scholar
  5. Gezondheidsraad: Diagnostiek en behandeling van ADHD. The Hague: Gezondheidsraad, 2000; publication no. 2000/24Google Scholar
  6. Cramer, JA, Mattson, RH, Prevey, ML, Sceyer, RD, Ouellette, VL. 1989How often is medication taken as prescribed?. A novel assessment techniqueJAMA26132737CrossRefPubMedGoogle Scholar
  7. Epstein, LH. 1984The direct effects of compliance on health outcomeHealth Psychol338593CrossRefPubMedGoogle Scholar
  8. Weintraub, M, Au, W, Lasagna, L. 1973Compliance as a determinant of serum digoxin concentrationJAMA2244815CrossRefPubMedGoogle Scholar
  9. Paes, AHP, Bakker, A, Soe-Agnie, CJ. 1997Impact of dosage frequency on patient’s complianceDiabetes Care2015126PubMedGoogle Scholar
  10. Pullar, T, Birtwell, AD, Wiles, PG, Hay, A, Freely, MP. 1988Use of a pharmacological indicator to investigate compliance with tablets to be taken once, twice or three times dailyClin Pharmacol Ther445405PubMedGoogle Scholar
  11. Swanson, J. 2003Compliance with stimulants for attention-deficit/hyperactivity disorderCNS Drugs1711731PubMedGoogle Scholar
  12. Firestone, P. 1982Factors associated with children’s adherence to stimulant medicationAm J Orthopsychiatr214749Google Scholar
  13. Brown, RT, Borden, KA, Wynne, ME, Spunt, AL, Clingerman, SR. 1987Compliance with pharmacological and cognitive treatments for attention deficit disorderJ Am Acad Child Adolesc Psychiatr265216Google Scholar
  14. Bussing, R, Gary, FA. 2001Practical guidelines and parental ADHD treatment evaluations: friends or foes?Harvard Rev Psychiatr922333CrossRefGoogle Scholar
  15. Steiner, JF. 1997The assessment of refill compliance using pharmacy records: methods, validity and applicationsJ Clin Epidemiol501056CrossRefPubMedGoogle Scholar
  16. Steiner, JF, Koepsell, TD, Fihn, SD, Inui, TS. 1988A general method of compliance assessment using centralized pharmacy recordsMed Care2681423PubMedGoogle Scholar
  17. Enlud, H. 1982Measuring patient compliance in antihypertensive therapy, some methodological aspectsJ Clin Hosp Pharm74351PubMedGoogle Scholar
  18. Greenhill, LL, Halperin, JM, Abikoff, H. 1999Stimulant medicationsJ Am Acad Child Adolesc Psychiatr3850312CrossRefGoogle Scholar
  19. Barkley, RA, McMurray, MB, Edelbrock, CS, Robbins, K. 1990Side effects of methylphenidate in children with attention deficit hyperactivity disorder: a systemic, placebo-controlled evaluationPediatrics8618492PubMedGoogle Scholar
  20. Efron, D, Jarman, F, Barker, M. 1997Side effect of methylphenidate and dexamphetamine in children with attention deficit hyperactivity disorder: a double-blind, crossover trialPediatrics1006626CrossRefPubMedGoogle Scholar
  21. Schachter, HM, Pham, B, King, J, Langford, S, Moher, D. 2001How efficacious and safe is short-acting methylphenidate for the treatment of attention-deficit disorder in children and adolescents?. A meta-analysisCan Med Ass J165147588Google Scholar
  22. Efron, D, Hiscock, H, Sewell, JR,  et al. 2003Prescribing psychotropic medication for children by Australian pediatricians and child psychiatristsPediatrics1113725CrossRefPubMedGoogle Scholar

Copyright information

© Springer 2005

Authors and Affiliations

  • Jacqueline G. Hugtenburg
    • 1
    Email author
  • Judith E. Griekspoor
    • 1
  • Ingrid De Boer
    • 1
  • Eibert R. Heerdink
    • 1
  • Yung Hwo Tso
    • 2
  • Antoine C. G. Egberts
    • 1
  1. 1.Department of Pharmacoepidemiology and Pharmacotherapy, Faculty of Pharmaceutical SciencesUtrecht UniversityUtrechtThe Netherlands
  2. 2.Practice for Child and Adolescent PsychiatryAmstelveenThe Netherlands

Personalised recommendations